Leukemia, Lymphoid
Showing 5276 - 5300 of 6,227
Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia, B-cell Precursor Acute Lymphoblastic Leukaemia, T-cell
Terminated
- Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia
- +2 more
-
Vienna, Austria
- +5 more
Oct 23, 2012
Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)
Terminated
- Preleukemia
- +4 more
- Fludarabine
- +2 more
-
Chicago, IllinoisThe Uniiversity of Chicago
Mar 14, 2014
Leukemia Trial in Houston (Procrit (epoetin alfa))
Completed
- Leukemia
- Procrit (epoetin alfa)
-
Houston, TexasUT MD Anderson Cancer Center
Jul 24, 2012
Accelerated Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +3 more
- dasatinib
- +3 more
-
Aurora, Colorado
- +1 more
Apr 1, 2014
Chronic Lymphocytic Leukemia Trial in Houston (Campath-1H, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
-
Houston, TexasUniversity of Texas - MD Anderson Cancer Center
Aug 1, 2012
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Stanford (biological, drug, other)
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +33 more
- oblimersen sodium
- +3 more
-
Stanford, CaliforniaStanford University
Jan 24, 2013
Acute Myeloid Leukemia Trial in Toronto (Elesclomol Sodium)
Unknown status
- Acute Myeloid Leukemia
- Elesclomol Sodium
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Jan 31, 2014
AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma Trial in Pittsburgh
Completed
- AIDS-related Peripheral/Systemic Lymphoma
- +52 more
- tanespimycin
- pharmacological study
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Feb 6, 2013
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Lenalidomide)
Completed
- Chronic Lymphocytic Leukemia
- Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Colon Cancer, Colorectal Cancer Trial in Los Angeles (capecitabine, imatinib mesylate)
Completed
- Colon Cancer
- Colorectal Cancer
- capecitabine, imatinib mesylate
-
Los Angeles, CaliforniaUSC/Norris Cancer Center
May 20, 2014
Leukemia, Lymphoma Trial in Philadelphia (rituximab, epirubicin HCl)
Completed
- Leukemia
- Lymphoma
- rituximab
- epirubicin hydrochloride
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 10, 2013
Chronic Lymphocytic Leukemia, Leukemia, Tumors Trial in Tianjin (Bendamustine Hydrochloride Injection, Chlorambucil)
Unknown status
- Chronic Lymphocytic Leukemia
- +2 more
- Bendamustine Hydrochloride Injection
- Chlorambucil
-
Tianjin, ChinaHematologic hospital of Chinese academy of medical sciences
Aug 3, 2012
Brain Tumor, Acute Lymphoblastic Leukemia Trial in Memphis (Computerized working memory training program (intervention),
Completed
- Brain Tumor
- Acute Lymphoblastic Leukemia
- Computerized working memory training program (intervention)
- Computerized working memory training program (control)
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 28, 2014
Advanced Hematologic Malignancies, Leukemia, Preleukemia Trial in Chicago (Clofarabine, Melphalan, Campath)
Completed
- Advanced Hematologic Malignancies
- +2 more
- Clofarabine
- +3 more
-
Chicago, IllinoisThe University of Chicago
Jan 9, 2014
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New Brunswick (rituximab, therapeutic allogeneic
Terminated
- Leukemia
- +2 more
- rituximab
- therapeutic allogeneic lymphocytes
-
New Brunswick, New JerseyCancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Sep 13, 2013
Leukemia Trial in Cleveland (alemtuzumab)
Completed
- Leukemia
- alemtuzumab
-
Cleveland, OhioIreland Cancer Center
Jan 7, 2014
Adenocarcinoma of the Colon, Stage III Colon Cancer Trial in Chicago (leucovorin calcium, fluorouracil, irinotecan HCl)
Completed
- Adenocarcinoma of the Colon
- Stage III Colon Cancer
- leucovorin calcium
- +3 more
-
Chicago, IllinoisCancer and Leukemia Group B
Oct 7, 2013
Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Oral Clofarabine)
Withdrawn
- Leukemia
- Chronic Lymphocytic Leukemia
- Oral Clofarabine
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Jul 31, 2012
Leukemia, Lung Cancer, Lymphoma Trial in New York (azacitidine, sodium phenylbutyrate)
Completed
- Leukemia
- +5 more
- azacitidine
- sodium phenylbutyrate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 20, 2013
Non-Hodgkin Lymphoma Trial in Worldwide (doxycycline (tetracycline))
Completed
- Non-Hodgkin Lymphoma
- doxycycline (tetracycline)
-
Providencia, Santiago, Chile
- +5 more
Nov 22, 2013
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Clofarabine)
Terminated
- Chronic Lymphocytic Leukemia
- Leukemia
-
Houston, TexasThe University of Texas M.D. Anderson Cancer Center
Jul 31, 2012
Lymphoma, Solid Tumor Trial (carbendazim)
Unknown status
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- (no location specified)
Sep 19, 2013